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is  the role of capsule
endoscopy? A case series
Enfermedad injerto contra huésped
gastrointestinal.  ¿Cuál es el papel de  la
cápsula endoscópica? Serie de casos
Allogeneic  hematopoietic  cell  transplantation  (AHCT)  is  an
essential  part  of  the  therapeutic  treatment  of  malignant
hematologic  diseases.  It  has  been  associated  with  frequent
complications,  such  as  infections  and  graft-versus-host  dis-
ease  (GVHD).  The  skin,  digestive  tract,  and  biliary  tract  are
the  main  organs  affected  by  GVHD.  It  is  the  most  impor-
tant  complication  and  is  associated  with  high  morbidity  and
mortality.  This  pathology  is  divided  into  acute  and  chronic
disease,  depending  on  whether  it  presents  before  or  after
the  ﬁrst  100  post-transplantation  days.1,2
Gastrointestinal  GVHD  can  manifest  as  nausea,  anorexia,
vomiting,  bloating,  diarrhea,  abdominal  pain,  bleeding,
ileus,  weight  loss,  and  fever  with  negative  cultures.  It  is
associated  with  an  80%  mortality  rate,  especially  in  cases
that  do  not  respond  to  ﬁrst-line  treatment.2,3 In  regard  to
its  gastrointestinal  involvement,  GVHD  diagnosis  is  based
on  panendoscopy  and  colonoscopy,  taking  biopsy  samples
from  the  antrum,  duodenum,  and  colon.  However,  the  small
bowel  is  the  most  affected  area,  given  that  it  is  the  most
extensive  immune  organ.4
GVHD  can  present  in  the  small  bowel  in  different  man-
ners,  affecting  it  by  segments  or  in  its  totality.  The  main
ﬁndings  in  this  organ  are  edema,  erythema,  erosions,  ulcers,
and  bleeding.5 Capsule  endoscopy  (CE)  is  a  noninvasive  tool
that  allows  us  to  observe  the  entire  small  bowel6 and  can  be
very  useful  in  accelerating  GVHD  diagnosis.  The  aim  of  this
report  is  to  communicate  the  usefulness  of  CE  in  patients
suspected  of  presenting  with  gastrointestinal  GVHD.
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the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-n 25-year-old  man  was  diagnosed  with  paroxysmal  nocturnal
emoglobinuria.  He  underwent  AHCT  on  May  14,  2015.  Thirty
ays  later  he  presented  with  abdominal  distension,  nausea,
nd  diarrhea.  Panendoscopy  and  colonoscopy  with  biopsy
ere  performed  and  the  CE  capsule  was  simultaneously
laced.  It  revealed  ﬂattened  villi  in  the  small  bowel,  as  well
s  edema  of  the  mucosa  and  vascular  pattern  loss.  Denuda-
ion  of  the  mucosa  was  present  in  some  segments,  along
ith  ﬁbrin-covered  ulcers,  fresh  blood,  and  clots.  The  CE
apsule  was  moved  into  the  duodenum  through  endoscopy
fter  remaining  in  the  stomach  for  6  h.  GVHD  diagnosis  was
orroborated  through  histopathology  one  week  later.  The
atient  did  not  respond  to  initial  management  and  so  was
iven  second-line  treatment.  He  responded  adequately  and
as  released  from  the  hospital.
ase 2
 37-year-old  man  was  diagnosed  with  chronic  myeloid
eukemia.  He  underwent  AHCT  on  June  30,  2015.  Twenty-
ine  days  after  the  transplantation  he  was  admitted  to  the
ospital  with  diarrhea,  nausea,  and  vomiting.  Panendoscopy
nd  colonoscopy  with  biopsy  were  performed,  together  with
E  capsule  placement.  The  capsule  identiﬁed  ﬂattened  villi
n  the  entire  small  bowel,  along  with  denudation  of  the
ucosa,  ulcers  that  caused  areas  of  stricture,  and  active
leeding.  The  histopathology  study  conﬁrmed  the  GVHD
iagnosis  10  days  later.  The  patient  is  currently  receiving
econd-line  treatment  for  steroid-refractory  disease.
ase 3
 45-year-old  man  was  diagnosed  with  acute  myelomono-
ytic  leukemia  and  underwent  AHCT  on  June  4,  2015.  On
he  54th  day  after  the  transplantation,  he  presented  with
ntermittent  colicky  abdominal  pain,  diarrhea,  nausea  and
omiting,  and  he  could  not  tolerate  an  oral  diet.  Two  days
ater  he  presented  with  hematochezia  on  17  occasions.
anendoscopy  and  colonoscopy  with  biopsy  were  performed.
he  CE  capsule  was  placed  and  showed  shortening  of  the
illi  in  the  jejunum  and  ileum,  as  well  as  erosions  and
ctive  bleeding  in  different  areas.  The  capsule  was  moved
 by Masson Doyma Me´xico S.A. This is an open access article under
d/4.0/).
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SFigure  1  Enteritis  due  to  GVHD.  A)  Stricture  second
nto  the  duodenum  through  endoscopy  after  remaining  in
he  stomach  for  4  h.  The  gastrointestinal  GVHD  diagnosis
as  conﬁrmed  through  histology  5  days  later.  The  patient
s  currently  responding  to  second-line  treatment  with
nﬂiximab.
Acute  GVHD  is  a  life-threatening  complication  of  AHCT.
ntestinal  involvement  occurs  in  up  to  46%  of  the  cases.
he  usefulness  of  CE  in  diagnosing  this  disease  is  becom-
ng  increasingly  relevant.  Neumann  et  al.  demonstrated  that
E  has  the  same  sensitivity  and  speciﬁcity  as  panendoscopy
ith  biopsy  in  acute  intestinal  GVHD.7 They  also  found  that  it
as  a  100%  negative  predictive  value,  as  previously  reported
y  Yakoub-Agha,  et  al.8 The  greatest  associated  impedi-
ent  is  gastric  retention  of  the  capsule,  which  can  occur
n  10.5-18%  of  the  cases,  due  to  a  probable  gastric  hypo-
otility  observed  in  these  patients.4,8 This  can  be  resolved
hrough  the  use  of  real  time  recorders  and  by  endoscopically
dvancing  the  capsules  that  have  remained  in  the  stom-
ch  for  long  periods.  The  principal  differential  diagnosis  is
iral  infection,  which  must  be  previously  ruled  out.  In  our
ases,  GVHD  diagnosis  by  CE  was  made  prior  to  the  histo-
athology  report,  thus  treatment  was  begun  early  (ﬁg.  1A
nd  B).
In  conclusion,  even  though  panendoscopy  and
olonoscopy  with  biopsy  is  the  criterion  standard,  CE
s  a  noninvasive  method  that  can  aid  in  the  diagnosis  of
astrointestinal  GVHD.  With  this  method,  it  is  not  neces-
ary  to  wait  for  the  histopathologic  result  and  the  risks
nvolved  in  invasive  endoscopic  explorations  are  avoided.
 larger  number  of  cases  are  required  to  conﬁrm  that  CE
s  a  complementary  diagnostic  method  in  gastrointestinal
VHD.
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(o  ulcer.  B)  Mucosa  with  villi  loss,  erosions,  and  ulcers.
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